HRP20191458T1 - Kompleksni spojevi željezo (iii) oksida s aktiviranim glukoznim sirupima i proces za pripremu istog - Google Patents

Kompleksni spojevi željezo (iii) oksida s aktiviranim glukoznim sirupima i proces za pripremu istog Download PDF

Info

Publication number
HRP20191458T1
HRP20191458T1 HRP20191458T HRP20191458T1 HR P20191458 T1 HRP20191458 T1 HR P20191458T1 HR P20191458 T HRP20191458 T HR P20191458T HR P20191458 T1 HRP20191458 T1 HR P20191458T1
Authority
HR
Croatia
Prior art keywords
iii
glucose syrup
iron
complex compound
activated
Prior art date
Application number
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Ioulia Tseti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioulia Tseti filed Critical Ioulia Tseti
Publication of HRP20191458T1 publication Critical patent/HRP20191458T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Claims (9)

1. Proces za pripremu kompleksnih spojeva željezo (III) hidroksida i aktiviranog glukoznog sirupa, pri čemu je molekularna težina kompleksa u rasponu od 100 kDa do 150 kDa, kako je izmjereno tekućinskom kromatografijom visokog učinka - gel permeacijskom kromatografijom (HPLC-GPC), naveden proces sadrži slijedeće korake: (i) dobivanje tekuće otopine glukoznog sirupa, dekstroznog ekvivalenta (DE) od najmanje 21 i najviše 60, kao što je utvrđeno gravimetrijskom analizom, temperature raspona od 25°C do 80°C i pH vrijednosti raspona od 6 do 13; (ii) dodavanje hidrogen peroksida, i, opcionalno, katalitičke količine oksidacijskog katalizatora, otopini u skladu s korakom (i), a istovremeno održavajući pH vrijednost i temperaturu u rasponu definiranom u prethodnom koraku (i), puštajući otopinu da se ohladi do temperature raspona od 10°C do 45°C, održavajući navedenu temperaturu otopine 5 min. do 24 sata, dobivajući time aktivirani glukozni sirup; (iii) pretvaranje navedenog aktiviranog glukoznog sirupa u kompleksni spoj sa željezo (III) hidroksidom; i (iv) dobivanje kompleksnog spoja željezo (III) hidroksida i aktiviranog glukoznog sirupa, pri čemu je korišteni hidrogen peroksid ukupne količine 0.0005-0.01 mol/g (glukozni sirup) pomnožen s faktorom korekcije: (dekstrozni ekvivalent glukoznog sirupa)/21, pri čemu kompleksni spoj ima sadržaj željeza raspona od 27 do 35%, temeljen na masi kompleksnog spoja; i pri čemu dobiveni kompleksni spoj željezo (III) hidroksida i aktivirani glukozni sirup imaju više od dvije –COOH grupe po molekuli glukoze i pri čemu glukozni sirup u skladu s korakom (i) nema nijednu –COOH grupu u molekuli glukoze.
2. Proces u skladu s patentnim zahtjevom 1, pri čemu je dekstrozni ekvivalent (DE) aktiviranog glukoznog sirupa raspona od 0,1 do 1,0, preferabilno otprilike 0,3 i/ili dobiveni kompleksni spoj željezo (III) hidroksida i aktiviranog glukoznog sirupa ima najmanje tri –COOH grupe po molekuli glukoze, što ukazuje da je glukozni sirup aktiviran.
3. Proces u skladu s bilo kojim od patentnih zahtjeva 1-2, pri čemu korak pretvaranja navedenog aktiviranog glukoznog sirupa u kompleksni spoj s željezovim (III) hidroksidom sadrži korake: (iii)(a) dodavanje otopine FeCl3 otopini u skladu s korakom (ii) temperature unutar raspona od 10 do 30°C; količina FeCl3 raspona od 30% masenog udjela do 120% masenog udjela količine glukoznog sirupa. (iii)(b) dodavanje anorganske baze reakcijskoj mješavini u skladu s korakom (iii)(a) dok pH vrijednost nije raspona od 1,5 do 2,5; i (iii)(c) zagrijavanje reakcijske mješavine u skladu s korakom (iii)(b) do temperature unutar raspona od 40 do 60°C.
4. Proces u skladu s bilo kojim od patentnih zahtjeva 1-3, pri čemu katalizator oksidacije uključuje ione broma i joda.
5. Kompleksni spoj željezo (III) hidroksida i glukoznog sirupa može se dobiti ili se dobiva procesom u skladu s bilo kojim od patentnih zahtjeva 1-4.
6. Farmaceutski spoj koji sadrži kompleksni spoj u skladu s patentnim zahtjevom 5.
7. Kompleksni spoj u skladu s patentnim zahtjevom 5 ili farmaceutski spoj u skladu s patentnim zahtjevom 6 za uporabu kao lijek.
8. Kompleksni spoj u skladu s patentnim zahtjevom 5 ili farmaceutski spoj u skladu s patentnim zahtjevom 6 za uporabu u metodi liječenja deficijencije željeza kod ljudi i životinja.
9. Kompleksni spoj ili farmaceutski spoj za uporabu u skladu s patentnim zahtjevom 8, pri čemu liječenje sadrži parenteralnu primjenu navedenog kompleksnog spoja u skladu s patentnim zahtjevom 5 ili farmaceutski spoj u skladu s patentnim zahtjevom 6.
HRP20191458 2014-09-22 2019-08-12 Kompleksni spojevi željezo (iii) oksida s aktiviranim glukoznim sirupima i proces za pripremu istog HRP20191458T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14386023.7A EP2997968A1 (en) 2014-09-22 2014-09-22 Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same
EP15739647.4A EP3197444B1 (en) 2014-09-22 2015-07-28 Iron (iii) hydroxide complexes with activated glucose syrups and process for preparing same
PCT/EP2015/067216 WO2016045826A1 (en) 2014-09-22 2015-07-28 Iron (iii) hydroxide complexes with activated glucose syrups and process for preparing same

Publications (1)

Publication Number Publication Date
HRP20191458T1 true HRP20191458T1 (hr) 2019-11-29

Family

ID=51730477

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191458 HRP20191458T1 (hr) 2014-09-22 2019-08-12 Kompleksni spojevi željezo (iii) oksida s aktiviranim glukoznim sirupima i proces za pripremu istog

Country Status (30)

Country Link
US (1) US20170232040A1 (hr)
EP (3) EP2997968A1 (hr)
AP (1) AP2017009747A0 (hr)
AU (1) AU2015320003C1 (hr)
BR (1) BR112017005614A2 (hr)
CA (1) CA2956870C (hr)
CL (1) CL2017000690A1 (hr)
CO (1) CO2017003488A2 (hr)
CY (1) CY1122133T1 (hr)
DK (1) DK3197444T3 (hr)
EA (1) EA033807B1 (hr)
ES (1) ES2740630T3 (hr)
GE (1) GEP20197004B (hr)
HR (1) HRP20191458T1 (hr)
HU (1) HUE044803T2 (hr)
IL (1) IL250615A0 (hr)
LT (1) LT3197444T (hr)
MA (2) MA50202A (hr)
MX (1) MX368219B (hr)
MY (1) MY187900A (hr)
PE (1) PE20170689A1 (hr)
PH (1) PH12017500316B1 (hr)
PL (1) PL3197444T3 (hr)
PT (1) PT3197444T (hr)
RS (1) RS59246B1 (hr)
SA (2) SA517381133B1 (hr)
SG (1) SG11201701408TA (hr)
SI (1) SI3197444T1 (hr)
WO (1) WO2016045826A1 (hr)
ZA (1) ZA201701899B (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009597B (el) 2018-04-16 2019-09-16 Ιουλια Κλεωνος Τσετη Φαρμακευτικο σκευασμα για την ενισχυση των επιπεδων σιδηρου στο αιμα, που περιεχει πολυμαλτοζικο σιδηρο (ιιι) και μια δραστικη ουσια επιλεγμενη απο πενταϋδρικο φυλλινικο ασβεστιο, βιταμινη c ή συνδυασμο των δυο, που ενισχυει την απορροφηση σιδηρου
TWI784646B (zh) * 2021-07-29 2022-11-21 台耀化學股份有限公司 製備羧基麥芽糖鐵的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885393A (en) 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
DE1293144B (de) 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
ZA711254B (en) 1970-03-13 1971-11-24 Fisons Ltd Treatment of iron deficiency in piglets
US3908004A (en) 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
US4180567A (en) 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE3422249A1 (de) 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
GB9514090D0 (en) 1995-07-11 1995-09-13 Cerestar Holding Bv Non-catalysed oxidation of maltodextrin with an oxygen containing oxidant
JP4520748B2 (ja) 2002-04-09 2010-08-11 ファーマコスモス、ホールディング、アクティーゼルスカブ 鉄欠乏性貧血の治療のための鉄デキストリン化合物
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.

Also Published As

Publication number Publication date
PE20170689A1 (es) 2017-06-03
EA033807B1 (ru) 2019-11-27
CA2956870A1 (en) 2016-03-31
AU2015320003A1 (en) 2017-03-09
CO2017003488A2 (es) 2017-07-11
DK3197444T3 (da) 2019-08-26
MX2017003708A (es) 2017-10-31
CA2956870C (en) 2018-12-11
BR112017005614A2 (pt) 2018-01-23
MY187900A (en) 2021-10-27
SI3197444T1 (sl) 2019-11-29
MA40322B1 (fr) 2019-08-30
HUE044803T2 (hu) 2019-11-28
EP3197444A1 (en) 2017-08-02
MX368219B (es) 2019-09-24
AP2017009747A0 (en) 2017-02-28
EP2997968A1 (en) 2016-03-23
SG11201701408TA (en) 2017-03-30
US20170232040A1 (en) 2017-08-17
WO2016045826A1 (en) 2016-03-31
AU2015320003B2 (en) 2018-04-26
EA201790673A1 (ru) 2017-09-29
PL3197444T3 (pl) 2019-12-31
RS59246B1 (sr) 2019-10-31
CL2017000690A1 (es) 2018-02-02
CY1122133T1 (el) 2020-11-25
ZA201701899B (en) 2018-05-30
MA50202A (fr) 2020-07-29
GEP20197004B (en) 2019-07-25
MA40322A (fr) 2016-03-23
EP3197444B1 (en) 2019-06-26
PH12017500316A1 (en) 2017-07-10
SA518392070B1 (ar) 2022-07-05
LT3197444T (lt) 2019-10-25
IL250615A0 (en) 2017-04-30
AU2015320003C1 (en) 2018-09-27
PT3197444T (pt) 2019-09-05
ES2740630T3 (es) 2020-02-06
PH12017500316B1 (en) 2017-07-10
EP3583941A1 (en) 2019-12-25
SA517381133B1 (ar) 2018-08-08

Similar Documents

Publication Publication Date Title
HRP20191458T1 (hr) Kompleksni spojevi željezo (iii) oksida s aktiviranim glukoznim sirupima i proces za pripremu istog
BR112013010865A2 (pt) produção de polímeros tipo pente por meio de esterificação
AU2018256550A1 (en) Compositions comprising crossed linked cation-binding polymers
EA201491866A1 (ru) Способ обработки волос
BR112014016185A2 (pt) processo para a produção de uma mistura de ácido 2,4-furandicarboxílico e ácido 2,5-furandicarboxílico (fdca) por meio de reação de dismutação, mistura de 2,4-fdca e 2,5-fdca obtenível por meio desta, 2,4-fdca obtenível por meio desta e uso de 2,4-fdca
JP2016510084A5 (hr)
MD20130067A2 (ro) Procedeu de obţinere a inulinei şi a altor produse cu conţinut de fructan din topinambur
MY163169A (en) Process for the preparation of an accelerator solution
WO2016137916A3 (en) Low temperature chemical strengthening process for glass
JP2016512688A5 (hr)
RU2006109914A (ru) Способ получения супрамолекулярного геля
WO2008105464A1 (ja) カルボン酸クロライドの製造方法
CN103772724A (zh) 一种壳聚糖果蔬保鲜膜的制备方法
BR112018012810A2 (pt) sensor eletroquímico e método de revestimento, método de produção e usos correspondentes
BR112017021125A2 (pt) catalisador para telomerização de butadieno e preparação do mesmo
BR112013002038A2 (pt) imobilização covalente de moléculas compreendendo um grupo amino
Alosmanov Kinetics investigation of the lead and zinc sorption by the phosphorus containing cationite
Yakovishin et al. Physico-Chemical Characteristic and Biological Activity of the Supramolecular Complex of Glycyram with β-Cyclodextrin
WO2012103170A3 (en) Tin(ii) 2-hydroxycarboxylates
TR201902897T4 (tr) (Met) akrilik asidin çözelti içinde polimerizasyonuna yönelik yöntem.
BR112019006833A2 (pt) métodos para determinar a heterogeneidade química de recipientes de vidro
JP2010202853A5 (hr)
CN105878222A (zh) 一种快速治疗冻疮的药物配方
RU2014138865A (ru) Способ извлечения серебра из технологических азотнокислых растворов
BRPI1106280A2 (pt) processo de produÇço de um poli (Ácido lÁtico) e alta massa molar, e, uso do poli (Ácido lÁtico) de alta massa molar